Research Protocol

SNAP-8 — Research Protocol

Dosage Calculator → How to Reconstitute →

Quickstart Highlights

SNAP-8 (Acetyl Octapeptide-3) is a synthetic octapeptide originally developed as a cosmeceutical ingredient for anti-wrinkle effects^[1]^[2]. It is an extended analog of the hexapeptide Argireline, designed to mimic part of the SNAP-25 protein involved in neuromuscular signaling^[5]. By competitively inhibiting SNAP-25 in the SNARE complex, SNAP-8 attenuates acetylcholine release at neuromuscular junctions, thereby relaxing facial muscle contractions without causing paralysis^[1]^[5]. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.
Typical daily range: 330–1,000 mcg once daily (gradual titration over 8–12 weeks).
Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing & Reconstitution Guide

Phase	Dose	Units (per injection)
Weeks 1–4	330mcg (0.33 mg)	10 UNites (0.10 mL)
Weeks 5-8	500mg (0.50 mg)	15 units (0.15 mL)
Weeks 9-12	1000mcg (1.0 mg)	30 units (0.30 mL)
Weeks 13-16 (Optional)	1000mcg (1.0 mg)	1000mcg (1.0 mg)

Frequency: Inject once daily subcutaneously. This schedule uses the largest practical dilution (3.0 mL) to keep per-injection units ≥10 for better accuracy. The gradual titration allows the body to acclimate while maximizing wrinkle-reduction benefits^[3]^[4].

Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration.

Peptide Vials (SNAP-8, 10 mg each):
- 8 weeks ≈ 3 vials
- 12 weeks ≈ 6 vials
- 16 weeks ≈ 8 vials
Insulin Syringes (U-100):
- Per week: 7 syringes (1/day)
- 8 weeks: 56 syringes
- 12 weeks: 84 syringes
- 16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
- 8 weeks (3 vials): 9 mL → 1 × 10 mL bottle
- 12 weeks (6 vials): 18 mL → 2 × 10 mL bottles
- 16 weeks (8 vials): 24 mL → 3 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
- Per week: 14 swabs (2/day)
- 8 weeks: 112 swabs → recommend 2 × 100-count boxes
- 12 weeks: 168 swabs → recommend 2 × 100-count boxes
- 16 weeks: 224 swabs → recommend 3 × 100-count boxes

Protocol Overview

Concise summary of the once-daily regimen.

Goal: Support reduction of expression lines and wrinkles through gentle muscle relaxation^[1]^[5].
Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
Dose Range: 330–1,000 mcg daily with gradual titration.
Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.
Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosing Protocol

Suggested daily titration approach.

Start: 330 mcg daily for first 4 weeks to acclimate.
Mid-Phase: Increase to 500 mcg daily (Weeks 5–8) if well tolerated.
Target: 1,000 mcg daily by Weeks 9–12 for maximum effect^[3]^[4].
Frequency: Once per day (subcutaneous).
Cycle Length: 8–12 weeks; optional extension to 16 weeks.
Timing: Any consistent time; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality.

Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure^[8].
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 30 days for maximum potency^[8].
Allow vials to reach room temperature before opening to reduce condensation uptake.
Avoid freeze–thaw: Do not refreeze reconstituted solution; prepare aliquots if needed.

How It Works

SNAP-8 is an extended analog of Argireline (hexapeptide) designed to mimic the SNAP-25 protein, which plays a crucial role in neurotransmitter release^[1]^[2]. By competitively inhibiting SNAP-25 in the SNARE complex, SNAP-8 reduces acetylcholine release at neuromuscular junctions, leading to gentle muscle relaxation^[5]. Unlike botulinum toxin (Botox) which cleaves SNAP-25 and causes muscle paralysis, SNAP-8 provides a milder, non-paralyzing effect that preserves natural facial expressions while reducing the depth of expression lines^[1]^[5]. Preclinical studies showed SNAP-8 demonstrated approximately 30% greater activity than Argireline in reducing neurotransmitter release, with enhanced formulation stability^[5].

Potential Benefits & Side Effects

Observations from preclinical and clinical literature.

Reduces wrinkle depth by an average of approximately 35%, with maximal improvements approaching 60% in certain areas after 28–30 days of consistent application in topical studies^[5].
A 24-subject clinical trial using dissolving microneedle patches containing SNAP-8 showed significant reduction in eye wrinkles and improved skin elasticity over 4 weeks, with no adverse effects reported^[4].
An open-label 14-week study of a multi-peptide serum including SNAP-8 noted statistically significant smoothing of expression lines with good tolerability and no serious side effects^[3].
Generally well tolerated; occasional mild injection-site reactions (temporary redness, swelling, or soreness) may occur with subcutaneous administration^[6].
No systemic toxicity observed at typical doses; no reports of unwanted muscle weakness or systemic effects^[5].

References

For laboratory and research use only. Minimum 98% purity. Not intended for human or animal consumption, medical, diagnostic, therapeutic or veterinary use. These statements have not been evaluated by the MHRA or FDA. This protocol is provided for educational and research purposes only and is not medical advice. The purchaser accepts full responsibility for safe handling, storage and lawful use.